The April formulary updates include the addition of 70 new National Drug Codes (NDCs), representing 42 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the April 2022 Formulary updates include six (6) newly-added brand-name drugs
The April drug data updates include nineteen (19) new brand-name drugs, six (6) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- ADBRY®,
- BYLVAY®,
- CORTROPHIN®,
- SKYTROFA®,
- TARPEYO®, and
- VOXZOGO®.
The April 2022 Formulary updates include five (5) newly-added generic drugs
The April Medicare Part D drug data also includes twenty-three (23) new generic medications, five (5) of which are newly-introduced generic drugs. These new generic drugs include:
- BRIMONIDINE-TIMOLOL [COMBIGAN®],
- ESTRADIOL VALERATE [DELESTROGEN®],
- LIDOCAINE [SOLUPAK®],
- LIDOCAINE HCL [XYLOCAINE®], and
- POTASSIUM CL [PROAMP®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- Your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of April 2022 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 70 new April 2022 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Delivery Form | 2 |
| New Drug | 18 |
| New Drug and Strength | 31 |
| New Drug, Delivery Form and Strength | 1 |
| New Manufacturer and Delivery Form | 1 |
| New Manufacturer and Strength | 9 |
| New Manufacturer, Strength and Delivery Form | 3 |
| New Strength | 5 |
| Grand Total | 70 |
The following chart details the 70 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 72143023130 | ACCUTANE 10 MG CAPSULE [ZENATANE] | 52 | 360 | New Strength |
| 50222034604 | ADBRY 150 MG/ML SYRINGE | 1 | 16 | New Drug |
| 57841120001 | AEMCOLO DR 194 MG TABLET DR | 0 | 17 | New Drug |
| 78206011201 | ASMANEX HFA 100 MCG INHALER HFA AER AD | 26 | 188 | New Drug and Strength |
| 78206011301 | ASMANEX HFA 200 MCG INHALER HFA AER AD | 26 | 188 | New Drug and Strength |
| 78206011101 | ASMANEX HFA 50 MCG INHALER HFA AER AD | 26 | 185 | New Drug and Strength |
| 78206011501 | ASMANEX TWISTHALER 110 MCG #30 AER POW BA | 26 | 187 | New Drug and Strength |
| 78206011401 | ASMANEX TWISTHALER 220 MCG #120 AER POW BA | 26 | 187 | New Drug and Strength |
| 78206011404 | ASMANEX TWISTHALER 220 MCG #30 AER POW BA | 26 | 187 | New Drug and Strength |
| 78206011402 | ASMANEX TWISTHALER 220 MCG #60 AER POW BA | 26 | 187 | New Drug and Strength |
| 51672134004 | BETAMETHASONE DP AUG 0.05% LOTION [Diprolene] | 53 | 379 | New Manufacturer and Delivery Form |
| 61958250501 | BIKTARVY 30-120-15 MG TABLET | 63 | 404 | New Strength |
| 60505622500 | BRIMONIDINE-TIMOLOL 0.2%-0.5% DROPS [Combigan] | 8 | 147 | New Drug |
| 74528012001 | BYLVAY 1,200 MCG CAPSULE | 4 | 99 | New Drug and Strength |
| 74528002001 | BYLVAY 200 MCG PELLET DSP CP | 4 | 99 | New Drug and Strength |
| 74528004001 | BYLVAY 400 MCG CAPSULE | 4 | 99 | New Drug and Strength |
| 78206011901 | CLARINEX 5 MG TABLET | 0 | 1 | New Drug |
| 78206012001 | CLARINEX-D 12 HR 2.5-120 MG TABLET TBMP 12HR | 1 | 18 | New Drug |
| 78670010001 | CORGARD 20 MG TABLET | 2 | 1 | New Manufacturer and Strength |
| 78670010101 | CORGARD 40 MG TABLET | 2 | 1 | New Manufacturer and Strength |
| 62559086015 | CORTROPHIN GEL 400 UNIT/5 ML VIAL | 1 | 71 | New Drug |
| 00310758090 | CRESTOR 20 MG TABLET | 2 | 1 | New Strength |
| 00310759030 | CRESTOR 40 MG TABLET | 2 | 1 | New Strength |
| 00172640649 | CROMOLYN 20 MG/2 ML NEB SOLN AMPUL-NEB [Intal] | 63 | 359 | New Drug |
| 71800000301 | CYCLOBENZAPRINE 7.5 MG TABLET [Fexmid] | 2 | 79 | New Drug |
| 68180094804 | DESOXIMETASONE 0.05% OINTMENT [Topicort LP] | 8 | 109 | New Delivery Form |
| 57664062388 | DEXMETHYLPHENIDATE ER 15 MG CPBP 50-50 [Focalin XR] | 7 | 120 | New Manufacturer and Strength |
| 57664062588 | DEXMETHYLPHENIDATE ER 30 MG CPBP 50-50 [Focalin XR] | 7 | 120 | New Manufacturer and Strength |
| 78206012402 | DIPROLENE 0.05% OINTMENT | 2 | 1 | New Drug |
| 78206012701 | DULERA 100 MCG-5 MCG INHALER HFA AER AD | 20 | 146 | New Drug and Strength |
| 78206012601 | DULERA 200 MCG-5 MCG INHALER HFA AER AD | 20 | 146 | New Drug and Strength |
| 78206012501 | DULERA 50 MCG-5 MCG INHALER HFA AER AD | 20 | 143 | New Drug and Strength |
| 45802046653 | ECONAZOLE NITRATE 1% CREAM (G) [Spectazole] | 39 | 299 | New Drug |
| 63739005366 | ERYTHROMYCIN 2% GEL [Erygel] | 27 | 249 | New Drug |
| 00517044001 | ESTRADIOL VALERATE 200 MG/5 ML VIAL [Delestrogen] | 34 | 297 | New Drug |
| 00713022360 | FLUOCINOLONE 0.01% CREAM (G) | 51 | 393 | New Drug |
| 51862015860 | FLURANDRENOLIDE 0.05% OINTMENT [Cordran] | 0 | 15 | New Manufacturer and Strength |
| 68180095102 | HYDROCORTISONE BUTYR 0.1% LOTION [Locoid] | 2 | 56 | New Delivery Form |
| 67877047379 | LIDOCAINE 5% OINTMENT [SOLUPAK] | 42 | 346 | New Manufacturer, Strength and Delivery Form |
| 00054350547 | LIDOCAINE HCL 4% SOLUTION [Xylocaine] | 53 | 368 | New Manufacturer, Strength and Delivery Form |
| 51862061501 | MORPHINE SULFATE IR 15 MG TABLET [MSIR] | 63 | 404 | New Manufacturer and Strength |
| 51862061701 | MORPHINE SULFATE IR 30 MG TABLET [MSIR] | 63 | 404 | New Manufacturer and Strength |
| 00093216568 | NALOXONE HCL 4 MG NASAL SPRAY [Narcan] | 57 | 369 | New Manufacturer, Strength and Delivery Form |
| 64380083622 | NYSTATIN-TRIAMCINOLONE OINTMENT [Mytrex] | 39 | 264 | New Drug |
| 59212070012 | ORAPRED ODT 10 MG TABLET RAPDIS | 0 | 9 | New Drug and Strength |
| 59212070112 | ORAPRED ODT 15 MG TABLET RAPDIS | 0 | 7 | New Drug and Strength |
| 59212070212 | ORAPRED ODT 30 MG TABLET RAPDIS | 0 | 7 | New Drug and Strength |
| 66992012814 | OTOVEL 0.3%-0.025% EAR DROPS VIAL | 1 | 2 | New Drug |
| 63323096730 | POTASSIUM CL 60 MEQ/30 ML CONC VIAL [PROAMP] | 52 | 380 | New Manufacturer and Strength |
| 70954004110 | RIFABUTIN 150 MG CAPSULE [Mycobutin] | 63 | 404 | New Drug |
| 65862068730 | RITONAVIR 100 MG TABLET [Norvir] | 63 | 404 | New Drug |
| 78206017201 | SINGULAIR 10 MG TABLET | 2 | 1 | New Drug and Strength |
| 78206017001 | SINGULAIR 4 MG CHEWABLE TABLET | 2 | 1 | New Drug and Strength |
| 78206017101 | SINGULAIR 4 MG GRANULES GRAN PACK | 2 | 1 | New Drug, Delivery Form and Strength |
| 78206017301 | SINGULAIR 5 MG CHEWABLE TABLET | 2 | 1 | New Drug and Strength |
| 73362001001 | SKYTROFA 11 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362001101 | SKYTROFA 13.3 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000301 | SKYTROFA 3 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000401 | SKYTROFA 3.6 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000501 | SKYTROFA 4.3 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000601 | SKYTROFA 5.2 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000701 | SKYTROFA 6.3 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000801 | SKYTROFA 7.6 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 73362000901 | SKYTROFA 9.1 MG CARTRIDGE | 0 | 27 | New Drug and Strength |
| 00338005403 | SODIUM CHLORIDE 3% IV SOLUTION | 35 | 303 | New Strength |
| 81749000401 | TARPEYO DR 4 MG CAPSULE DR | 4 | 20 | New Drug |
| 70752012905 | TRIAMCINOLONE 0.025% LOTION [Kenalog] | 52 | 393 | New Manufacturer and Strength |
| 68135008236 | VOXZOGO 0.4 MG VIAL | 0 | 33 | New Drug and Strength |
| 68135011966 | VOXZOGO 0.56 MG VIAL | 0 | 33 | New Drug and Strength |
| 68135018193 | VOXZOGO 1.2 MG VIAL | 0 | 33 | New Drug and Strength |
You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.